Kaleido Biosciences, Inc. — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021)

$1.1M

Net Income/Loss (FY2021)

-$90.3M

Total Assets (FY2021)

$50.1M

Total Equity (FY2021)

$10.6M

Cash Flows from Operating Activities (FY2021)

-$77.1M

Source: Kaleido Biosciences, Inc. 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.